🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A non-androgen targeted approach might be an alternative in patients with metastatic castration resistant prostate cancer who have progressive disease with ARPI❓ CONTACT-02 Phase ⤵️ ✅Cabozantinib + atezolizumab significantly improved progression-free survival vs ARPI switch

🚨 Our new study alert! Elsevier What is the role of comorbidity burden in response to immunotherapy based combos in patients with metastatic renal cell carcinoma? 🎯Endpoints : Overall surival and time to treatment failure High comorbidity 🟰 Worse Outcomes ❓❗️No

🌟Calling all Hem/Onc fellowship applicants!! Sign up here: docs.google.com/forms/d/1H0oJ2…

🚨Proud to share our publication in JCO Oncology Practice 🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc IMG Oncologists gilberto lopes

Honored to be part of this!! Congratulations on this important work Arya Roy Toni Choueiri, MD Nazli Dizman Nazli Dizman et al

🎙 Neeraj Agarwal, MD, FASCO of Huntsman Cancer Institute and Dr. Jeanny Aragon-Ching of Inova Schar Cancer Institute highlight key innovations in GU cancer research from #ASCO25 on a new episode of the #ASCODailyNews Podcast: bit.ly/4elzewZ

#Cardiovascular management in advanced #ProstateCancer. Zeynep Irem Ozay, MD Huntsman Cancer Institute sits down with Neeraj Agarwal, MD, FASCO to discuss research on the impact of statins in patients with advanced prostate cancer treated with apalutamide. #WatchNow on UroToday > bit.ly/3XBtcRK

1/ Thrilled to share our work on Chromophobe RCC (ChRCC) and Renal Oncocytic Neoplasms (RONs) out Journal of Clinical Oncology !!! Incredibly thankful to my mentors David Braun Toni Choueiri, MD Eli Van Allen and all co-authors Dana-Farber BIDMC IM Residency Yale University Brigham and Women's Hospital Link: ascopubs.org/doi/10.1200/JC…

So honored to receive this prestigious award by ECOG-ACRIN Cancer Research Group kudos to all investigators/staff who work hard to conduct trials globally! PrECOG Naomi Haas MJ Jean Hoffman-Censits Dr. Tom Lynch Nicole D. Fleming MD Amer Zeidan MBBS,MHS ‏عامر زيدان Manmeet Ahluwalia, MD, MBA, FASCO Shilpa Gupta OncoAlert Tian Zhang, MD, MHS

Fantastic! Keep an eye out for Jasnoor Malhotra & #ASchlager, two rising MS3s who are both going to make stellar future oncologists! Thanks Cristiane D Bergerot for mentoring them!

🤩Preclinical and clinical data on #Ivonescimab in other cancers shows an immense promise for our patients with #KidneyCancer 🙏Thanks Pavlos Msaouel Andy Hahn for your mentorship in developing this protocol #IVORY. ✨Looking forward to enrolling our patients and learning more

🙋‍♀️Hello!! How's your schedule this fall? 🌟#WomenInOncology, save Sep 27-28 for #LEAD25! It's a fantastic opportunity for career development, networking with many inspiring and impactful women in oncology! 👉 bioascend.com/lead/ Dr. Julie Brahmer Ana I. Velázquez Mañana, MD, MSc, FASCO Dr. Catherine Lai

📢 Access to healthcare can be a powerful determinant of patient outcomes This large cohort study published in JCO Global Oncology investigates the impact of treatment funding source on survival in patients with bladder cancer. 📌 Among 6,217 patients: 🔹 5-year OS in

Humbled to share my (very first) primary authored paper: Top 10 Tips for #hpm about #survonc Deeply grateful for my writing mentor Gregg Robbins-Welty, MD, MS, HEC-C senior author Larissa Nekhlyudov wisdom of Nicolas Hart and colleagues, mentees and friends Samina B. Martin, MD with editorial insight of

We've made a last minute substitution! Tomorrow (7/9/25) at 6 pm PST, please tune in to hear Miguel Zugman City of Hope & Nataliya Mar UC Irvine discuss updates in #kidneycancer with MOASC President Ashkan! Space is still available. Register for this terrific event at

1/ Happy to share our latest piece in npj Journals precision oncology: "Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer". Work co-led with Karl Semaan, MD, MSc with great mentorship from @Jberchuck Sylvan Baca MD PhD (Hiring!) #MattFreedman Toni Choueiri, MD

Breaking News from ph3 Embark trial👉Enzalutamide+ADT improve overall survival (OS) vs. ADT alone in Non-Metastatic HSPC #Prostatecancer Congrats to Stephen Freedland, MD neal shore & team! Earlier enza works better! Link👉 rb.gy/iyc3f2 OncoAlert UroToday.com Prostate Cancer Foundation

Congratulations to this year's #WorldGU25 poster winners! We are excited to spotlight our 19 winners at the Poster Session & Welcome Reception at the 2-day CE-accredited conference in Nashville, TN, Aug 21-23. Join us and receive up to 11.75 CE credits. hubs.la/Q03wLfxZ0

✨ What a comprehensive review by Regina Barragan-Carrillo Zeynep Zengin and great mentor Sumanta K. Pal, MD, FASCO on relation between #microbiome and #immunotherapy response! Muharrem Coşkunpınar OncoAlert ASCO Journal of Clinical Oncology #Cancer #MedX #Oncology doi.org/10.1200/JCO-25…

Check out our paper on microbiome modulation strategies in cancer! ascopubs.org/doi/pdf/10.120… Appreciate Sumanta K. Pal, MD, FASCO’s mentorship and and amazing Regina Barragan-Carrillo for including me!